{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:25:17Z","timestamp":1787034317351,"version":"build-2736575974"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K16802"],"award-info":[{"award-number":["23K16802"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K21093"],"award-info":[{"award-number":["26K21093"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Oncol. Rev."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) develops in a chronically inflamed hepatic environment shaped by innate immune signaling, tissue injury, and microenvironmental remodeling. Toll-like receptor 4 (TLR4) signaling and pyroptosis are frequently discussed together in this context because both connect danger sensing to inflammatory output. However, marker-associated changes in TLR4 expression, inflammasome-related proteins, cytokine release, or lytic cell death do not necessarily establish a causally defined TLR4-to-pyroptosis pathway. This Perspective examines the unresolved interface between TLR4-associated inflammatory priming and pyroptosis-related execution in hepatoma-cell systems, with particular attention to the distinction between conceptual overlap and mechanistic continuity. I further discuss geranylgeranoic acid (GGA), an endogenous diterpenoid acid with reported anti-hepatoma activity, for which a functional contribution of TLR4-associated signaling has been reported in HuH-7 cells, although direct receptor engagement and generalizability across hepatoma models remain unestablished. Accordingly, GGA is considered a hypothesis-generating experimental probe to refine questions concerning receptor-complex modulation, membrane microenvironment remodeling, stress- or danger-signal-mediated amplification, and inflammatory cell-death susceptibility. Overall, the available evidence supports a cautious but experimentally tractable framework in which TLR4-associated signaling may contribute to inflammatory priming and, under permissive conditions, intersect with pyroptosis-related outcomes. Defining this interface will require direct tests of pathway dependence, temporal ordering, and execution-level validation.<\/jats:p>","DOI":"10.3389\/or.2026.1882953","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:37:06Z","timestamp":1787031426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Geranylgeranoic acid, toll-like receptor 4, and pyroptosis-related signaling in hepatocellular carcinoma: a hypothesis-generating perspective"],"prefix":"10.3389","volume":"20","author":[{"given":"Yuki","family":"Tabata","sequence":"first","affiliation":[{"name":"Department of Nursing, Faculty of Nursing, Miyazaki Prefectural Nursing University","place":["Miyazaki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2174\/0118715206364200250304034753","article-title":"Gut microbiota and the gut-liver axis in hepatocellular carcinoma: a comprehensive review of pathogenesis and therapeutic strategies","volume":"25","author":"Yadav","year":"2025","journal-title":"Anticancer Agents Med Chem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/diseases13070207","article-title":"Hepatocellular carcinoma: a comprehensive review","volume":"13","author":"Amin","year":"2025","journal-title":"Diseases"},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh","year":"2016","journal-title":"J Hepatocell Carcinoma"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/ijms23073778","article-title":"Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options","volume":"23","author":"Sas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","article-title":"Pyroptosis: molecular mechanisms and roles in disease","volume":"35","author":"Broz","year":"2025","journal-title":"Cell Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13402-023-00787-9","article-title":"The role of pyroptosis in hepatocellular carcinoma","volume":"46","author":"Zou","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1522206","DOI":"10.3389\/fcell.2025.1522206","article-title":"Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives","volume":"13","author":"Yang","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): New insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immun Ageing"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","article-title":"Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis","volume":"20","author":"Giannelli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1055\/s-0030-1255353","article-title":"Toll-like receptor 4 and hepatic fibrogenesis","volume":"30","author":"Pradere","year":"2010","journal-title":"Semin Liver Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-1536-3-21","article-title":"Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis","volume":"3","author":"Guo","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0151063","DOI":"10.1371\/journal.pone.0151063","article-title":"TLR4-Dependent secretion by hepatic stellate cells of the neutrophil-chemoattractant CXCL1 mediates liver response to gut microbiota","volume":"11","author":"Bigorgne","year":"2016","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.20350","article-title":"Selective priming to toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-Regulation of MD-2 in mice","volume":"40","author":"Romics","year":"2004","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"BSR20194118","DOI":"10.1042\/BSR20194118","article-title":"TLR4-Mediated pyroptosis in human hepatoma-derived HuH-7 cells induced by a branched-chain polyunsaturated fatty acid, geranylgeranoic acid","volume":"40","author":"Yabuta","year":"2020","journal-title":"Biosci Reports"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100396","DOI":"10.1016\/J.JLR.2023.100396","article-title":"Geranylgeranoic acid, a bioactive and endogenous fatty acid in mammals: a review","volume":"64","author":"Shidoji","year":"2023","journal-title":"J Lipid Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/metabo11090634","article-title":"Age-dependent decrease in hepatic geranylgeranoic acid content in C3H\/HeN mice and its oral supplementation prevents spontaneous hepatoma","volume":"11","author":"Tabata","year":"2021","journal-title":"Metabolites"},{"key":"B19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.36922\/EJMO025330352","article-title":"Endogenous and dietary geranylgeranoic acid: a mini review on its role in hepatic tumor suppression","volume":"9","author":"Tabata","year":"2025","journal-title":"Eurasian J Med Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1194\/jlr.RA119000610","article-title":"Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells","volume":"61","author":"Tabata","year":"2020","journal-title":"J Lipid Research"},{"key":"B21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/METABO12020140","article-title":"Hepatic CYP3A4 enzyme compensatively maintains endogenous geranylgeranoic acid levels in MAOB-knockout human hepatoma cells","volume":"12","author":"Tabata","year":"2022","journal-title":"Metabolites"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0132761","DOI":"10.1371\/journal.pone.0132761","article-title":"Polyunsaturated branched-chain fatty acid geranylgeranoic acid induces unfolded protein response in human hepatoma cells","volume":"10","author":"Iwao","year":"2015","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/BJ20110610","article-title":"Induction of an incomplete autophagic response by cancer-preventive geranylgeranoic acid (GGA) in a human hepatoma-derived cell line","volume":"440","author":"Okamoto","year":"2011","journal-title":"Biochem J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fimmu.2014.00473","article-title":"Molecular and cellular regulation of toll-like Receptor-4 activity induced by lipopolysaccharide ligands","volume":"5","author":"Liaunardy-Jopeace","year":"2014","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1189\/jlb.2MR0316-117RR","article-title":"Molecular mechanisms of regulation of toll-like receptor signaling","volume":"100","author":"Leifer","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"672395","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflamm"},{"key":"B30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cells9010216","article-title":"Role of TLR4 receptor complex in the regulation of the innate immune response by fibronectin","volume":"9","author":"Zheng","year":"2020","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","article-title":"MD-2 is required for disulfide HMGB1-Dependent TLR4 signaling","volume":"212","author":"Yang","year":"2015","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/eji.201444462","article-title":"Postulates for validating TLR4 agonists","volume":"45","author":"Man\u010dek-Keber","year":"2015","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","article-title":"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran","volume":"130","author":"Kim","year":"2007","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"66656","DOI":"10.18632\/oncotarget.19105","article-title":"The role of toll-like receptor 4 in tumor microenvironment","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/JHC.S44515","article-title":"Emerging role of toll-like receptor 4 in hepatocellular carcinoma","volume":"2","author":"Yang","year":"2015","journal-title":"J Hepatocell Carcinoma"},{"key":"B38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of Lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol Int"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8419","DOI":"10.3390\/ijms23158419","article-title":"Persistent TLR4 activation promotes hepatocellular carcinoma growth through positive feedback regulation by LIN28A\/Let-7g miRNA","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.25500","article-title":"Toll-like receptor 4-Dependent kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury","volume":"55","author":"El Kasmi","year":"2012","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/cam4.2070","article-title":"TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma","volume":"8","author":"Zhou","year":"2019","journal-title":"Cancer Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1872-034X.2011.00822.x","article-title":"Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis","volume":"41","author":"Seki","year":"2011","journal-title":"Hepatol Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/pharmaceutics15102460","article-title":"Interplay of extracellular vesicles and TLR4 signaling in hepatocellular carcinoma pathophysiology and therapeutics","volume":"15","author":"Papadakos","year":"2023","journal-title":"Pharmaceutics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cytogfr.2025.08.002","article-title":"TLR-based therapeutic strategies for hepatocellular carcinoma","volume":"85","author":"Gupta","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","article-title":"Mechanistic insights into gasdermin-mediated pyroptosis","volume":"26","author":"Bai","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/2394-4722.2025.90","article-title":"Chronic inflammation and immune response in hepatocellular carcinoma: a comprehensive literature review","volume":"12","author":"Alsudaney","year":"2026","journal-title":"J Cancer Metastasis Treat"},{"key":"B49","doi-asserted-by":"publisher","first-page":"122627","DOI":"10.1016\/j.lfs.2024.122627","article-title":"Burning down the house: pyroptosis in the tumor microenvironment of hepatocellular carcinoma","volume":"347","author":"Cheng","year":"2024","journal-title":"Life Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41420-024-02116-x","article-title":"Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects","volume":"10","author":"Wu","year":"2024","journal-title":"Cell Death Discov"},{"key":"B51","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","article-title":"The role of pyroptosis in cancer: pro-cancer or pro-host","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1218807","DOI":"10.3389\/fcell.2023.1218807","article-title":"Pyroptosis and gasdermins-emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis","volume":"11","author":"Stoess","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/s41596-020-0374-9","article-title":"A comprehensive guide to studying inflammasome activation and cell death","volume":"15","author":"Tweedell","year":"2020","journal-title":"Nat Protoc"},{"key":"B54","doi-asserted-by":"publisher","first-page":"C784","DOI":"10.1152\/ajpcell.00503.2023","article-title":"Pyroptosis in health and disease","volume":"326","author":"Imre","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s12672-025-02907-3","article-title":"Single cell analysis and bioinformatics reveal pyroptosis mechanisms in hepatocellular carcinoma","volume":"16","author":"Luo","year":"2025","journal-title":"Discov Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41416-024-02908-z","article-title":"Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma","volume":"132","author":"Deng","year":"2025","journal-title":"Br J Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/cancers14010048","article-title":"Cell death in hepatocellular carcinoma: pathogenesis and therapeutic opportunities","volume":"14","author":"Garc\u00eda-Pras","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jcmgh.2016.03.006","article-title":"NOD-like receptor protein 3 inflammasome priming and activation in barrett\u2019s epithelial cells","volume":"2","author":"Nadatani","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","article-title":"TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in alzheimer\u2019s disease","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","article-title":"TRIF licenses Caspase-11-Dependent NLRP3 inflammasome activation by gram-negative bacteria","volume":"150","author":"Rathinam","year":"2012","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through Caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","article-title":"Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during yersinia infection","volume":"115","author":"Sarhan","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s12672-025-03035-8","article-title":"Targeting inflammatory pathways in hepatocellular carcinoma: recent developments","volume":"16","author":"Ramaite","year":"2025","journal-title":"Discov Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"B66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41420-024-02285-9","article-title":"Pir-Hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation","volume":"11","author":"Liao","year":"2025","journal-title":"Cell Death Discov"},{"key":"B67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13046-018-0872-6","article-title":"Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours","volume":"37","author":"Nwosu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/cancers15030592","article-title":"A high-throughput sequencing data-based classifier reveals the metabolic heterogeneity of hepatocellular carcinoma","volume":"15","author":"Ye","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3390\/cancers15102795","article-title":"The role of TLR4 in the immunotherapy of hepatocellular carcinoma: can we teach an old dog new tricks?","volume":"15","author":"Papadakos","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.2147\/JIR.S427868","article-title":"Programmed cell death in liver fibrosis","volume":"16","author":"Gao","year":"2023","journal-title":"J Inflamm Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1680031","DOI":"10.3389\/fragi.2025.1680031","article-title":"Geranylgeranoic acid and the MAOB\u2013CYP3A4 axis: a metabolic shift underlying age-related liver cancer risk","volume":"6","author":"Tabata","year":"2025","journal-title":"Front Aging"},{"key":"B73","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1194\/jlr.M090548","article-title":"Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells","volume":"60","author":"Shidoji","year":"2019","journal-title":"J Lipid Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/jcb.20627","article-title":"Prevention of geranylgeranoic acid-induced apoptosis by phospholipid hydroperoxide glutathione peroxidase gene","volume":"97","author":"Shidoji","year":"2006","journal-title":"J Cell Biochem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/01635581.2012.655401","article-title":"Rapid downregulation of cyclin D1 induced by geranylgeranoic acid in human hepatoma cells","volume":"64","author":"Shimonishi","year":"2012","journal-title":"Nutr Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1038\/srep04419","article-title":"Induction of nuclear translocation of mutant cytoplasmic P53 by geranylgeranoic acid in a human hepatoma cell line","volume":"4","author":"Iwao","year":"2014","journal-title":"Scientific Reports"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1194\/jlr.M300502-JLR200","article-title":"Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbs","volume":"45","author":"Shidoji","year":"2004","journal-title":"J Lipid Research"},{"key":"B78","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MOL.0b013e328082e4d5","article-title":"Membrane lipids as signaling molecules","volume":"18","author":"Fernandis","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MOL.0000000000000443","article-title":"Membrane lipids and cell signaling","volume":"28","author":"Sunshine","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e1663","DOI":"10.7717\/peerj.1663","article-title":"LPS- or pseudomonas aeruginosa-mediated activation of the macrophage TLR4 signaling Cascade depends on membrane lipid composition","volume":"4","author":"Schoeniger","year":"2016","journal-title":"PeerJ"},{"key":"B81","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","article-title":"Co-Operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling","volume":"72","author":"P\u0142\u00f3ciennikowska","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.bbamem.2015.03.014","article-title":"Role of lipid microdomains in TLR-mediated signalling","volume":"1848","author":"Ruysschaert","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B83","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/nu10040432","article-title":"Obesity, inflammation, toll-like receptor 4 and fatty acids","volume":"10","author":"Rogero","year":"2018","journal-title":"Nutrients"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0837","DOI":"10.1097\/HC9.0000000000000837","article-title":"Lipid metabolism in cancer cells: its role in hepatocellular carcinoma progression and therapeutic resistance","volume":"9","author":"Wong","year":"2025","journal-title":"Hepatol Commun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.ctm.2019.07.001","article-title":"Structural and signaling role of lipids in plasma membrane repair","volume":"84","author":"Horn","year":"2019","journal-title":"Curr Top Membr"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","article-title":"The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis","volume":"99","author":"Bolourani","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/cancers12061668","article-title":"Glucose metabolism and oxidative stress in hepatocellular carcinoma: role and possible implications in novel therapeutic strategies","volume":"12","author":"Mossenta","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B89","doi-asserted-by":"publisher","first-page":"101803","DOI":"10.1016\/j.smim.2023.101803","article-title":"Pyroptosis and the cellular consequences of gasdermin pores","volume":"69","author":"Huston","year":"2023","journal-title":"Semin Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"167297","DOI":"10.1016\/j.jmb.2021.167297","article-title":"Mechanistic insights into gasdermin pore formation and regulation in pyroptosis","volume":"434","author":"Wang","year":"2022","journal-title":"J Mol Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10777","DOI":"10.3390\/ijms231810777","article-title":"Hepatic stellate cell modulates the immune microenvironment in the progression of hepatocellular carcinoma","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expert Rev Gastroenterol and Hepatol"}],"container-title":["Oncology Reviews"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2026.1882953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:37:07Z","timestamp":1787031427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2026.1882953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":92,"alternative-id":["10.3389\/or.2026.1882953"],"URL":"https:\/\/doi.org\/10.3389\/or.2026.1882953","relation":{},"ISSN":["1970-5557"],"issn-type":[{"value":"1970-5557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1882953"}}